908 Devices (MASS) EBT Margin (2020 - 2026)
908 Devices' (MASS) quarterly EBT Margin came in at 111.18% in Q1 2026, down 28.0% year-on-year from 154.42% in Q1 2025, and down 558.76% on a QoQ basis from 24.23% in Q4 2025.
908 Devices (MASS) EBT Margin (2020 - 2026) Analysis & Trends
908 Devices (MASS) has 7 years of EBT Margin data on file, last reported at 111.18% in Q1 2026.
- On a quarterly basis, EBT Margin fell 28.0% year-over-year to 111.18% in Q1 2026; TTM through Mar 2026 was 66.41%, a 4934.0% increase from a year earlier, with the FY2025 full-year figure at 59.33%, up 5196.0% from the prior year.
- EBT Margin for Q1 2026 stood at 111.18%, down from 24.23% in the prior quarter.
- Over the last five years, EBT Margin for MASS reached as high as 24.23% in Q4 2025 and fell as low as 162.88% in Q3 2024.
- Historically, EBT Margin has averaged 89.91% across 5 years, with a median of 98.48% in 2025.
- Across the five-year window, EBT Margin plunged 11266 bps in 2024 and soared 13595 bps in 2025, its largest moves.
- Year by year, EBT Margin stood at 84.09% in 2022, then jumped by 38 bps to 51.78% in 2023, then plunged by 116 bps to 111.72% in 2024, then soared by 122 bps to 24.23% in 2025, then sank by 559 bps to 111.18% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 111.18% in Q1 2026, 24.23% in Q4 2025, and 106.25% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | 908 Devices | 261.78 Mn | 150.04 Mn | 6.88 Mn | -111.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -111.18% |
| Dec 31, 2025 | 24.23% |
| Sep 30, 2025 | -106.25% |
| Jun 30, 2025 | -98.48% |
| Mar 31, 2025 | -110.90% |
| Dec 31, 2024 | -111.72% |
| Sep 30, 2024 | -162.88% |
| Jun 30, 2024 | -66.07% |
| Mar 31, 2024 | -148.03% |
| Dec 31, 2023 | -51.78% |
| Sep 30, 2023 | -50.22% |
| Jun 30, 2023 | -77.87% |
| Mar 31, 2023 | -132.10% |
| Dec 31, 2022 | -84.09% |
| Sep 30, 2022 | -39.62% |
| Jun 30, 2022 | -72.92% |
| Mar 31, 2022 | -128.57% |
| Dec 31, 2021 | -26.99% |
| Sep 30, 2021 | -51.47% |
| Jun 30, 2021 | -102.03% |